Variant report
Variant | nsv975184 |
---|---|
Chromosome Location | chr11:56124251-56126625 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr11:56125074-56125141 | GM13976 | blood: | n/a | n/a |
2 | POLR2A | chr11:56124985-56125245 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | SPI1 | chr11:56125544-56125711 | GM12878 | blood: | n/a | n/a |
4 | SPI1 | chr11:56125521-56125712 | GM12891 | blood: | n/a | n/a |
5 | SPI1 | chr11:56125541-56125709 | GM12891 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPL5P29 | TF binding region |
OR8J1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11228123 | chr11:56124635-56124636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs527875668 | chr11:56124658-56124659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs564094965 | chr11:56124660-56124661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs141001845 | chr11:56124676-56124677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs546961820 | chr11:56124714-56124715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs181589321 | chr11:56124751-56124752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs376848765 | chr11:56124772-56124773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs185705155 | chr11:56124799-56124800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548153025 | chr11:56124800-56124801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs113014181 | chr11:56124807-56124808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554393587 | chr11:56124825-56124826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs76927240 | chr11:56124838-56124839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs61903530 | chr11:56124864-56124865 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs374583377 | chr11:56124866-56124867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572885726 | chr11:56124867-56124868 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs112921748 | chr11:56124869-56124870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs555896603 | chr11:56124897-56124898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs144909568 | chr11:56124903-56124904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs574678092 | chr11:56124933-56124934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs541622036 | chr11:56124938-56124939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs1967011 | chr11:56124943-56124944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs138742313 | chr11:56124945-56124946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs148932554 | chr11:56124957-56124958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs545895324 | chr11:56124962-56124963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564204640 | chr11:56124970-56124971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs143633242 | chr11:56124973-56124974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs61903531 | chr11:56124976-56124977 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs59418539 | chr11:56124985-56124986 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs148114044 | chr11:56125009-56125010 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs555027786 | chr11:56125026-56125027 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs572751815 | chr11:56125028-56125029 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs571951274 | chr11:56125029-56125030 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs61737622 | chr11:56125042-56125043 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs12271906 | chr11:56125043-56125044 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs12419960 | chr11:56125117-56125118 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs61745317 | chr11:56125123-56125124 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs150638417 | chr11:56125126-56125127 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs533892219 | chr11:56125140-56125141 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs555739243 | chr11:56125142-56125143 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs568232303 | chr11:56125173-56125174 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs372964445 | chr11:56125174-56125175 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs182695921 | chr11:56125184-56125185 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs372343332 | chr11:56125203-56125204 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs375581154 | chr11:56125224-56125225 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs9705184 | chr11:56125243-56125244 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs528908965 | chr11:56125542-56125543 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs546523055 | chr11:56125555-56125556 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs544487727 | chr11:56125584-56125585 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs191155854 | chr11:56125617-56125618 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs533343459 | chr11:56125648-56125649 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:56124600-56125200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |